Loading…
Employees: 428
Size SR Medical Technology (0108.HK) is a Hong Kong Real Estate company (Real Estate Development) with a market value of $972M, the 600th largest of 891 Hong Kong companies the cockpit tracks. Shares closed at HK$2.29 on 6 Nov 2026.
Performance Over six months the shares fell 9.7%, against -30.3% for the median peer and -13.4% for the Hong Kong market (cap-weighted) — 8th highest of 20 in its peer set.
Growth Revenue grew 24.5% over the last twelve months (peer median -3.0%); the operating margin is 3.6% (peer median -0.1%).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | HK$404M | HK$349M | HK$340M | HK$377M | HK$392M |
| Revenue growth | — | +3% | -10% | -4% | — |
| Gross profit | n/a | n/a | HK$337M | HK$373M | HK$382M |
| EBITDA | HK$21.4M | HK$67.4M | HK$85.2M | HK$144M | HK$141M |
| Net income | -HK$182M | -HK$110M | -HK$919M | -HK$129M | -HK$320M |
| Free cash flow | HK$147M | HK$14.2M | -HK$42.3M | HK$15.4M | -HK$180M |
| Capital expenditure | HK$1.26M | HK$2.73M | HK$1.15M | HK$965,000 | HK$922,000 |
| Total debt | n/a | HK$4.05B | HK$3.83B | HK$3.87B | HK$3.56B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 0108.HK | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -6.3% | -8.6% | 11th highest of 21 |
| 6-month return | -9.7% | -30.3% | 8th highest of 20 |
| Distance from 52-week high | -46.4% | -36.3% | 8th lowest of 21 |
| Revenue growth (TTM) | +24.5% | -3.0% | 3rd highest of 20 |
| Operating margin | 3.6% | -0.1% | 8th highest of 19 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| SR Medical Technology 0108.HK | Hong Kong | $972M | -10% | +25% | 4% | n/a | n/a | n/a |
| Heiwa Real Estate 8803.T | Japan | $964M | -6% | +23% | 30% | n/a | n/a | n/a |
| Jiangsu Dagang 002077.SZ | China | $983M | -32% | +24% | -8% | n/a | n/a | n/a |
| Hefei Urban Construction Development 002208.SZ | China | $961M | -42% | -14% | -1% | n/a | n/a | n/a |
| PropNex OYY.SI | Singapore | $956M | -9% | +8% | 6% | n/a | n/a | n/a |
| Ningbo Fuda 600724.SS | China | $956M | -37% | -18% | 15% | n/a | n/a | n/a |
| Financial Street 000402.SZ | China | $991M | -30% | -38% | -26% | n/a | n/a | n/a |
| Shanghai Industrial Development 600748.SS | China | $952M | -35% | -3% | 0% | n/a | n/a | n/a |
| Develia DVL.WA | Poland | $947M | -26% | +70% | 23% | n/a | n/a | n/a |
| HMC Capital HMC.AX | Australia | $946M | +17% | -27% | 27% | n/a | n/a | n/a |
| WeWork India Management WEWORK.NS | India | $1.00B | +26% | +25% | 24% | n/a | n/a | n/a |
| Shanghai AJ 600643.SS | China | $1.00B | -12% | -41% | -180% | n/a | n/a | n/a |
| Fermi FRMI | United States | $1.01B | -70% | n/a | n/a | n/a | n/a | n/a |
| China Sports Industry 600158.SS | China | $1.01B | -41% | 0% | -9% | n/a | n/a | n/a |
| Suzhou New District Hi-Tech Industrial 600736.SS | China | $934M | -34% | -30% | -27% | n/a | n/a | n/a |
| Shunfa Hengneng 000631.SZ | China | $922M | -9% | +9% | n/a | n/a | n/a | n/a |
| 5I5J 000560.SZ | China | $1.03B | -2% | -21% | -6% | n/a | n/a | n/a |
| Sveafastigheter SVEAF-B.ST | Sweden | $916M | n/a | +8% | 51% | n/a | n/a | n/a |
| Beijing Capital Development 600376.SS | China | $1.04B | -41% | -35% | -15% | n/a | n/a | n/a |
| Black Peony (Group) 600510.SS | China | $1.04B | -37% | -24% | -14% | n/a | n/a | n/a |
| Marcus & Millichap MMI | United States | $1.05B | -9% | +12% | 1% | n/a | n/a | n/a |